Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-034116
Filing Date
2010-06-21
Accepted
2010-06-21 16:30:39
Documents
1
Period of Report
2010-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd279585.html 4  
1 FORM 4 rrd279585.xml 4 3921
  Complete submission text file 0001181431-10-034116.txt   5943
Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
Ruscher Robert P (Reporting) CIK: 0001106813 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34641 | Film No.: 10908289

Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Issuer) CIK: 0001484478 (see all company filings)

EIN.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations